Prostate cancer early detection, version 1.2014: Featured updates to the NCCN guidelines

Peter R. Carroll; J. Kellogg Parsons; Gerald Andriole; Robert R. Bahnson; Daniel A. Barocas; William J. Catalona; Douglas M. Dahl; John W. Davis; Jonathan I. Epstein; Ruth B. Etzioni; Veda N. Giri; George P. Hemstreet; Mark H. Kawachi; Paul H. Lange; Kevin R. Loughlin; William Lowrance; Paul Maroni; James Mohler; Todd M. Morgan; Robert B. Nadler; Michael Poch; Chuck Scales; Terrence M. Shanefelt; Andrew J. Vickers; Robert Wake; Dorothy A. Shead; Maria Ho

doi:10.6004/jnccn.2014.0120

Prostate cancer early detection, version 1.2014: Featured updates to the NCCN guidelines

Peter R. Carroll
, J. Kellogg Parsons
, Gerald Andriole
, Robert R. Bahnson
, Daniel A. Barocas
, William J. Catalona
, Douglas M. Dahl
, John W. Davis
, Jonathan I. Epstein
, Ruth B. Etzioni
, Veda N. Giri
, George P. Hemstreet
, Mark H. Kawachi
, Paul H. Lange
, Kevin R. Loughlin
, William Lowrance
, Paul Maroni
, James Mohler
, Todd M. Morgan
, Robert B. Nadler

Michael Poch, Chuck Scales, Terrence M. Shanefelt, Andrew J. Vickers, Robert Wake, Dorothy A. Shead, Maria Ho

Department of Urology

University of California at San Francisco
University of California at San Diego
Washington University St. Louis
Ohio State University
Vanderbilt University
Northwestern University
Massachusetts General Hospital Cancer Center
University of Texas MD Anderson Cancer Center
Johns Hopkins University
Seattle Cancer Care Alliance
Fox Chase Cancer Center
Nebraska Medicine
City of Hope National Med Center
Dana-Farber
University of Utah
University of Colorado Anschutz Medical Campus
University of Michigan, Ann Arbor
Moffitt Cancer Center
Duke University
University of Alabama at Birmingham
Memorial Sloan-Kettering Cancer Center
University of Tennessee Health Science Center
National Comprehensive Cancer Network

Research output: Contribution to journal › Article › peer-review

83 Scopus citations

Abstract

The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for men choosing to participate in an early detection program for prostate cancer. These NCCN Guidelines Insights highlight notable recent updates. Overall, the 2014 update represents a more streamlined and concise set of recommendations. The panel stratified the age ranges at which initiating testing for prostate cancer should be considered. Indications for biopsy include both a cutpoint and the use of multiple risk variables in combination. In addition to other biomarkers of specificity, the Prostate Health Index has been included to aid biopsy decisions in certain men, given recent FDA approvals.

Original language	English
Pages (from-to)	1211-1219
Number of pages	9
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	12
Issue number	9
DOIs	https://doi.org/10.6004/jnccn.2014.0120
State	Published - Sep 1 2014

Access to Document

10.6004/jnccn.2014.0120

Cite this

Carroll, P. R., Parsons, J. K., Andriole, G., Bahnson, R. R., Barocas, D. A., Catalona, W. J., Dahl, D. M., Davis, J. W., Epstein, J. I., Etzioni, R. B., Giri, V. N., Hemstreet, G. P., Kawachi, M. H., Lange, P. H., Loughlin, K. R., Lowrance, W., Maroni, P., Mohler, J., Morgan, T. M., ... Ho, M. (2014). Prostate cancer early detection, version 1.2014: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 12(9), 1211-1219. https://doi.org/10.6004/jnccn.2014.0120

@article{88c58c4f239642cd84dbf1b6d714e26b,

title = "Prostate cancer early detection, version 1.2014: Featured updates to the NCCN guidelines",

abstract = "The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for men choosing to participate in an early detection program for prostate cancer. These NCCN Guidelines Insights highlight notable recent updates. Overall, the 2014 update represents a more streamlined and concise set of recommendations. The panel stratified the age ranges at which initiating testing for prostate cancer should be considered. Indications for biopsy include both a cutpoint and the use of multiple risk variables in combination. In addition to other biomarkers of specificity, the Prostate Health Index has been included to aid biopsy decisions in certain men, given recent FDA approvals.",

author = "Carroll, \{Peter R.\} and Parsons, \{J. Kellogg\} and Gerald Andriole and Bahnson, \{Robert R.\} and Barocas, \{Daniel A.\} and Catalona, \{William J.\} and Dahl, \{Douglas M.\} and Davis, \{John W.\} and Epstein, \{Jonathan I.\} and Etzioni, \{Ruth B.\} and Giri, \{Veda N.\} and Hemstreet, \{George P.\} and Kawachi, \{Mark H.\} and Lange, \{Paul H.\} and Loughlin, \{Kevin R.\} and William Lowrance and Paul Maroni and James Mohler and Morgan, \{Todd M.\} and Nadler, \{Robert B.\} and Michael Poch and Chuck Scales and Shanefelt, \{Terrence M.\} and Vickers, \{Andrew J.\} and Robert Wake and Shead, \{Dorothy A.\} and Maria Ho",

year = "2014",

month = sep,

day = "1",

doi = "10.6004/jnccn.2014.0120",

language = "English",

volume = "12",

pages = "1211--1219",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "9",

}

Carroll, PR, Parsons, JK, Andriole, G, Bahnson, RR, Barocas, DA, Catalona, WJ, Dahl, DM, Davis, JW, Epstein, JI, Etzioni, RB, Giri, VN, Hemstreet, GP, Kawachi, MH, Lange, PH, Loughlin, KR, Lowrance, W, Maroni, P, Mohler, J, Morgan, TM, Nadler, RB, Poch, M, Scales, C, Shanefelt, TM, Vickers, AJ, Wake, R, Shead, DA & Ho, M 2014, 'Prostate cancer early detection, version 1.2014: Featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 12, no. 9, pp. 1211-1219. https://doi.org/10.6004/jnccn.2014.0120

TY - JOUR

T1 - Prostate cancer early detection, version 1.2014

T2 - Featured updates to the NCCN guidelines

AU - Carroll, Peter R.

AU - Parsons, J. Kellogg

AU - Andriole, Gerald

AU - Bahnson, Robert R.

AU - Barocas, Daniel A.

AU - Catalona, William J.

AU - Dahl, Douglas M.

AU - Davis, John W.

AU - Epstein, Jonathan I.

AU - Etzioni, Ruth B.

AU - Giri, Veda N.

AU - Hemstreet, George P.

AU - Kawachi, Mark H.

AU - Lange, Paul H.

AU - Loughlin, Kevin R.

AU - Lowrance, William

AU - Maroni, Paul

AU - Mohler, James

AU - Morgan, Todd M.

AU - Nadler, Robert B.

AU - Poch, Michael

AU - Scales, Chuck

AU - Shanefelt, Terrence M.

AU - Vickers, Andrew J.

AU - Wake, Robert

AU - Shead, Dorothy A.

AU - Ho, Maria

PY - 2014/9/1

Y1 - 2014/9/1

N2 - The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for men choosing to participate in an early detection program for prostate cancer. These NCCN Guidelines Insights highlight notable recent updates. Overall, the 2014 update represents a more streamlined and concise set of recommendations. The panel stratified the age ranges at which initiating testing for prostate cancer should be considered. Indications for biopsy include both a cutpoint and the use of multiple risk variables in combination. In addition to other biomarkers of specificity, the Prostate Health Index has been included to aid biopsy decisions in certain men, given recent FDA approvals.

AB - The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for men choosing to participate in an early detection program for prostate cancer. These NCCN Guidelines Insights highlight notable recent updates. Overall, the 2014 update represents a more streamlined and concise set of recommendations. The panel stratified the age ranges at which initiating testing for prostate cancer should be considered. Indications for biopsy include both a cutpoint and the use of multiple risk variables in combination. In addition to other biomarkers of specificity, the Prostate Health Index has been included to aid biopsy decisions in certain men, given recent FDA approvals.

UR - https://www.scopus.com/pages/publications/84907288188

U2 - 10.6004/jnccn.2014.0120

DO - 10.6004/jnccn.2014.0120

M3 - Article

C2 - 25190691

AN - SCOPUS:84907288188

SN - 1540-1405

VL - 12

SP - 1211

EP - 1219

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 9

ER -

Prostate cancer early detection, version 1.2014: Featured updates to the NCCN guidelines

Abstract

Access to Document

Other files and links

Fingerprint

Cite this